Our hypothesis-driven approach revealed that higher COVID-19 disease severity was associated with an increased number of interactions between IL6 and other multi-omics layers, therefore suggesting that our approach may discriminate between COVID-19 and other respiratory disorders. This evidence concerns the gene IL6 and respiratory system disorder.